These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11465968)

  • 1. Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery.
    Poldermans D; Boersma E; Bax JJ; Thomson IR; Paelinck B; van de Ven LL; Scheffer MG; Trocino G; Vigna C; Baars HF; van Urk H; Roelandt JR;
    Eur Heart J; 2001 Aug; 22(15):1353-8. PubMed ID: 11465968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.
    Poldermans D; Boersma E; Bax JJ; Thomson IR; van de Ven LL; Blankensteijn JD; Baars HF; Yo TI; Trocino G; Vigna C; Roelandt JR; van Urk H
    N Engl J Med; 1999 Dec; 341(24):1789-94. PubMed ID: 10588963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing cardiac risk in noncardiac surgery.
    Lee TH
    N Engl J Med; 1999 Dec; 341(24):1838-40. PubMed ID: 10588971
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-blockade and surgery.
    Prichard BN; Robin JM
    Eur Heart J; 2001 Aug; 22(15):1253-5. PubMed ID: 11465960
    [No Abstract]   [Full Text] [Related]  

  • 5. Bisoprolol prevents mortality and myocardial infarction after vascular surgery.
    Dickerson LM; Carek PJ
    J Fam Pract; 2000 Mar; 49(3):203-4. PubMed ID: 10735475
    [No Abstract]   [Full Text] [Related]  

  • 6. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
    Dunkelgrun M; Boersma E; Schouten O; Koopman-van Gemert AW; van Poorten F; Bax JJ; Thomson IR; Poldermans D;
    Ann Surg; 2009 Jun; 249(6):921-6. PubMed ID: 19474688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy.
    Boersma E; Poldermans D; Bax JJ; Steyerberg EW; Thomson IR; Banga JD; van De Ven LL; van Urk H; Roelandt JR;
    JAMA; 2001 Apr; 285(14):1865-73. PubMed ID: 11308400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up.
    Zaugg M; Bestmann L; Wacker J; Lucchinetti E; Boltres A; Schulz C; Hersberger M; Kälin G; Furrer L; Hofer C; Blumenthal S; Müller A; Zollinger A; Spahn DR; Borgeat A
    Anesthesiology; 2007 Jul; 107(1):33-44. PubMed ID: 17585213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing long-term cardiac management after major vascular surgery: Role of beta-blocker therapy, clinical characteristics, and dobutamine stress echocardiography to optimize long-term cardiac management after major vascular surgery.
    Kertai MD; Boersma E; Bax JJ; Thomson IR; Cramer MJ; van de Ven LL; Scheffer MG; Trocino G; Vigna C; Baars HF; van Urk H; Roelandt JR; Poldermans D;
    Arch Intern Med; 2003 Oct; 163(18):2230-5. PubMed ID: 14557221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative and long-term cardiovascular outcomes in patients undergoing endovascular treatment compared with open vascular surgery for abdominal aortic aneurysm or iliaco-femoro-popliteal bypass.
    Schouten O; van Waning VH; Kertai MD; Feringa HH; Bax JJ; Boersma E; Elhendy A; Biagini E; van Sambeek MR; van Urk H; Poldermans D
    Am J Cardiol; 2005 Sep; 96(6):861-6. PubMed ID: 16169378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockade for patients undergoing vascular surgery.
    Litwack RS; Gilligan DM; DeGruttola V
    N Engl J Med; 2000 Apr; 342(14):1052; author reply 1052-3. PubMed ID: 10755897
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-blockade for patients undergoing vascular surgery.
    Feldman T; Fusman B; McKinsey JF
    N Engl J Med; 2000 Apr; 342(14):1051-2; author reply 1052-3. PubMed ID: 10755896
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.
    Circulation; 1994 Oct; 90(4):1765-73. PubMed ID: 7923660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study.
    Schouten O; Poldermans D; Visser L; Kertai MD; Klein J; van Urk H; Simoons ML; van de Ven LL; Vermeulen M; Bax JJ; Lameris TW; Boersma E
    Am Heart J; 2004 Dec; 148(6):1047-52. PubMed ID: 15632892
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of a clinical and scintigraphic management strategy for cardiac risk before abdominal aorta surgery. Apropos of 982 surgical patients].
    Vanzetto G; Sessa C; Magne JL; Guidicelli H; Ormezzano O; Fagret D; Blin D; Gattaz F; Machecourt J
    Arch Mal Coeur Vaiss; 1999 Feb; 92(2):211-8. PubMed ID: 10078340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study.
    Erne P; Schoenenberger AW; Zuber M; Burckhardt D; Kiowski W; Dubach P; Resink T; Pfisterer M
    Eur Heart J; 2007 Sep; 28(17):2110-7. PubMed ID: 17644512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction].
    Sárosi I; Debreceni G; Mühl D; Kónyi A; Bogár L; Tekeres M; Tóth K; Habon T; Czopf L; Zámbó K; Schmidt E
    Orv Hetil; 1997 Aug; 138(31):1939-45. PubMed ID: 9280886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a nurse-led intervention to optimize beta-blockade for reducing cardiac events after major noncardiac surgery.
    Marwick TH; Branagan H; Venkatesh B; Stewart S;
    Am Heart J; 2009 Apr; 157(4):784-90. PubMed ID: 19332211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dobutamine stress echocardiography prior to aortic surgery: long-term cardiac outcome.
    Bigatel DA; Franklin DP; Elmore JR; Nassef LA; Youkey JR
    Ann Vasc Surg; 1999 Jan; 13(1):17-22. PubMed ID: 9878652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of prophylactic coronary revascularization in cardiac high-risk patients undergoing major vascular surgery (from the randomized DECREASE-V Pilot Study).
    Schouten O; van Kuijk JP; Flu WJ; Winkel TA; Welten GM; Boersma E; Verhagen HJ; Bax JJ; Poldermans D;
    Am J Cardiol; 2009 Apr; 103(7):897-901. PubMed ID: 19327412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.